Mumbai: All-on-4® treatment concept that stands for “All teeth on only four dental implants” is an ingenious dental implant protocol specifically innovated over twenty years ago by world-renowned European implantologist Dr. Paulo Malo (founder and CEO of the now global MALO CLINICS) in association with leading implant company Nobel Biocare, to provide edentulous or soon-to-be edentulous patients with a new, non-removable bridge supported by only four strategically placed dental implants.
During his visit to India, Dr. Malo conducted a master class to educate dental implant professionals on how patients can have Immediate Function and excellent aesthetics with a limited number of implants, and to and shared his global experience. Dr. Malo performed two live surgeries in the master class to demonstrate this technique. The treated patients expressed happiness as they walked out of surgery with an immediately delivered, fully functional set of teeth.
Classified as a disability by the WHO (World Health Organization), edentulism affects 60 million people in India alone, with 91.2% of the nation’s elderly population toothless to some degree. These patients experience rapid permanent loss of the underlying jaw bone which can contribute to nutritional deficiencies (due to the inability to chew solid food) and speech impairment. In addition, patients do not feel confident to smile, which can impact their emotional and psychological health as well.
According to the Indian Journal of Dental Research, the majority of patients remain untreated for edentulism. Until recently, patients only had two suitable treatment options; removable dentures and dental implant surgery. Approximately 40% of patients choose removable dentures but it only restores 10% of the normal teeth function and it does not prevent the underlying bone loss. A conventional dental implant surgery requires placing 6-8 implants per jaw. In many of these cases, patients require bone grafting before implants are placed because this situation is accompanied by bone loss. The associated additional cost and time (12–18 months) delays relief (a set of functional teeth) for the patients.
Dr. Malo’s breakthrough in dental technology was designed to keep the patient’s needs and concerns at the forefront. This new minimally invasive surgery requires no bone grafting and allows patients to walk out the same day with functional teeth. In addition, the All-on-4® treatment concept can be more cost effective due to the fact it only requires four implants.
Dr. Malo says, “The use of angulated implants at the back to overcome deficient bone and/or anatomical limitations is what sets the All-on-4® procedure apart from other treatments. It reduces, and in many cases eliminates, the need for bone grafting. The quick recovery time and long-term success of the treatment can make a world of difference for the patients. Imagine coming out of an implant surgery; being able to bite straight on a juicy apple! The dream of new fixed teeth can now be a reality for patients and help them enjoy a quality life once more.” (Business Wire India)
About Prof. Paulo Malo
Prof. Paulo Malo received his dental degree from the Faculty of Dental Medicine at the University of Lisbon in 1989. He founded the MALO CLINIC in 1995 where he developed the MALO CLINIC Protocol (surgical techniques and innovative products such as the All-on-4® treatment concept, a new Zygoma™ implant and protocol, the NobelSpeedy™ implant and the advanced technical solution MALO CLINIC BRIDGE), recognized worldwide by the dental and medical community as setting a new standard in Fixed Oral Rehabilitation. Prof. Malo is a visiting professor at several universities, has published numerous scientiﬁc journal articles and is a co-author of several textbooks.
About Nobel Biocare
Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company’s portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including key brands NobelActive®, Brånemark System® and NobelReplace®), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), diagnostics, treatment planning and guided surgery solutions (NobelClinician® and NobelGuide®) and biomaterials (creos™). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland. Production takes place at five sites located in the United States, Sweden, Japan and Israel. Products and services are available in over 80 countries through subsidiaries and distributors.